Cardiovascular research (Cardiovasc Res)

Journal PubWeight™ 8485.56‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Structure and function of matrix metalloproteinases and TIMPs. 2006 8.26
2 The inflammatory response in myocardial infarction. 2002 7.92
3 Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. 2003 5.39
4 Role of microRNAs in vascular diseases, inflammation, and angiogenesis. 2008 4.95
5 MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. 2009 4.88
6 Electrical, contractile and structural remodeling during atrial fibrillation. 2002 4.86
7 Structural and functional characterisation of cardiac fibroblasts. 2005 4.79
8 The reasons why clinical cardiologists disregard reperfusion arrhythmias. 1993 4.63
9 The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. 2006 4.38
10 Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. 2004 4.00
11 Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. 2005 3.99
12 The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. 1988 3.98
13 Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection. 2004 3.96
14 Pericytes in the microvasculature. 1996 3.95
15 Molecular mechanisms of blood vessel growth. 2001 3.94
16 The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. 2013 3.92
17 Sense and nonsense about the impact factor. 1997 3.90
18 The role of oxidants and free radicals in reperfusion injury. 2006 3.83
19 Gap junctions and the connexin protein family. 2004 3.66
20 New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. 2004 3.63
21 Early and late effects of exercise and athletic training on neural mechanisms controlling heart rate. 1993 3.61
22 Electrophysiological remodeling in hypertrophy and heart failure. 1999 3.43
23 Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. 2004 3.40
24 Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. 2001 3.39
25 Reduction in density of transverse tubules and L-type Ca(2+) channels in canine tachycardia-induced heart failure. 2001 3.39
26 Blockers of ATP sensitive potassium current are of potential benefit in ischaemic heart disease. 1994 3.33
27 Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha. 2007 3.31
28 MicroRNAs: novel regulators in cardiac development and disease. 2008 3.30
29 Morphologic and biochemical hallmarks of apoptosis. 2000 3.28
30 The biology of vascular endothelial growth factors. 2005 3.22
31 TGF-beta1 and angiotensin networking in cardiac remodeling. 2004 3.20
32 Cytokines and atherosclerosis: a comprehensive review of studies in mice. 2008 3.16
33 Protective and pathological roles of nitric oxide in endotoxin shock. 1992 3.15
34 The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. 2007 3.15
35 Reduced synchrony of Ca2+ release with loss of T-tubules-a comparison to Ca2+ release in human failing cardiomyocytes. 2004 3.10
36 Cardiomyocyte cell cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nuclei. 2010 3.00
37 Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. 2007 2.98
38 Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. 2008 2.97
39 A modified axial lead system for orthogonal lead electrocardiography. 1969 2.97
40 Drugs which alter nitric oxide homeostasis are unlikely to provide therapeutic benefit in cardiovascular disease. 1993 2.96
41 Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. 1994 2.91
42 Diagnosis of valvular heart disease using transcutaneous Doppler ultrasound. 1977 2.90
43 Transmural repolarisation in the left ventricle in humans during normoxia and ischaemia. 2001 2.89
44 The sinoatrial node, a heterogeneous pacemaker structure. 2000 2.89
45 TGF-beta signaling in vascular fibrosis. 2007 2.86
46 Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. 1992 2.86
47 Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? 2002 2.84
48 Measurement of the angina threshold using atrial pacing. A new technique for the study of angina pectoris. 1967 2.84
49 Hypertrophic obstructive cardiomyopathy, a histological, histochemical, and ultrastructural study of biopsy material. 1971 2.84
50 Altered phosphorylation and Ca2+-sensitivity of myofilaments in human heart failure. 2003 2.82
Next 50